NTI — Neurotech International Balance Sheet
0.000.00%
- AU$19.94m
- AU$16.91m
- AU$2.58m
Annual balance sheet for Neurotech International, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | AAS | AAS | AAS | AAS | AAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 4.83 | 1.9 | 5.03 | 11.6 | 3.03 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.143 | 0.099 | 0.258 | 0.318 | 0.089 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 5.01 | 2.02 | 5.31 | 12.2 | 3.24 |
Net Property, Plant And Equipment | 0 | 0.003 | 0.001 | 0 | 0 |
Total Assets | 5.01 | 2.02 | 5.31 | 12.2 | 3.24 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Current Liabilities | 0.349 | 0.593 | 1.35 | 0.315 | 0.286 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 1.14 | 0.593 | 1.35 | 0.315 | 0.286 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 3.86 | 1.43 | 3.96 | 11.9 | 2.95 |
Total Liabilities & Shareholders' Equity | 5.01 | 2.02 | 5.31 | 12.2 | 3.24 |
Total Common Shares Outstanding |